NeoGenomics
Carlos Portillo is a finance professional with extensive experience in various roles within the healthcare and pharmaceutical industries. Currently serving as Finance Business Partner for Lab Operations at NeoGenomics Laboratories since September 2023, Carlos previously worked as a Finance Pharma-Biotech Industry Expert Advisor at Guidepoint from September 2022 to September 2023. Carlos has a long tenure at Roche, spanning from January 2004 to May 2022, where responsibilities included Global Business Insights and Analytics, Finance and Resources Manager for PDGA LATAM, and Manager of Finance PDGA. Educational qualifications include a CMA in Management from The Society of Management Accountants of Ontario obtained between January 2007 and January 2009, as well as a Post-Graduate Diploma in Finance from Tecnológico de Monterrey completed in January 2001.
This person is not in any teams
This person is not in any offices
NeoGenomics
9 followers
NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years.